Search Results - "Burmeister, Bryan"

Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma.

Authors: Reading, Dwayne Burmeister, Bryan

Source: Case Reports in Gastroenterology. 2022, Vol. 16 Issue 2, p333-338. 6p.

Development of the Melanoma Concerns Questionnaire (MCQ-28); refinement of the EORTC QLQ-MEL38 module.

Authors: Winstanley, Julie White, Edward Saw, Robyn et al.

Source: Psycho-Oncology. Feb2020, Vol. 29 Issue 2, p321-330. 10p. 3 Charts, 1 Graph.

Subjects: Melanoma, Rasch models, Principal components analysis, Goodness-of-fit tests

Geographic Terms: Serbia

Neurotropic Melanoma: The Management of Localised Disease.

Authors: Croker, Jeremy Burmeister, Bryan Foote, Matthew

Source: Journal of Skin Cancer. 2012, p1-6. 6p. 2 Color Photographs, 1 Black and White Photograph.

Two cases of esophageal carcinoma following corrosive esophagitis successfully treated with chemoradiation therapy.

Authors: Burmeister, Bryan H. Walpole, Euan T. Thomas, Janine et al.

Source: Asia Pacific Journal of Clinical Oncology. Jun2007, Vol. 3 Issue 2, p108-111. 4p.

T1-2 anal carcinoma requires elective inguinal radiation treatment – The results of Trans Tasman Radiation Oncology Group study TROG 99.02

Authors: Matthews, John H.L. Burmeister, Bryan H. Borg, Martin et al.

Source: Radiotherapy & Oncology. Jan2011, Vol. 98 Issue 1, p93-98. 6p.

Subjects: Cancer radiotherapy, Anal cancer treatment, Cancer chemotherapy, Fluorouracil, Survival analysis (Biometry), Mitomycin C

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Authors: Burmeister, Bryan H. Mark Smithers, B. Burmeister, Elizabeth et al.

Source: Radiotherapy & Oncology. Nov2006, Vol. 81 Issue 2, p136-142. 7p.

Subjects: Melanoma, Radiotherapy, Neuroendocrine tumors, Lymph nodes

Second primary oesophageal cancer following radiation for breast cancer

Authors: Matheson, J. Bronwyn Burmeister, Bryan H. Smithers, B. Mark et al.

Source: Radiotherapy & Oncology. Dec2002, Vol. 65 Issue 3, p159. 5p.

Subjects: Breast cancer, Tumors, Esophageal cancer

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

Authors: Henderson, Michael A Burmeister, Bryan H Ainslie, Jill et al.

Source: Lancet Oncology. Sep2015, Vol. 16 Issue 9, p1049-1060. 12p.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

Authors: Burmeister, Bryan H Henderson, Michael A Ainslie, Jill et al.

Source: Lancet Oncology. Jun2012, Vol. 13 Issue 6, p589-597. 9p.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

Authors: Sjoquist, Katrin M Burmeister, Bryan H Smithers, B Mark et al.

Source: Lancet Oncology. Jul2011, Vol. 12 Issue 7, p681-692. 12p.

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

Authors: Burmeister, Bryan H. Thomas, Janine M. Burmeister, Elizabeth A. et al.

Source: European Journal of Cancer. Feb2011, Vol. 47 Issue 3, p354-360. 7p.

DESMOPLASTIC MELANOMA: THE ROLE OF RADIOTHERAPY IN IMPROVING LOCAL CONTROL.

Authors: Foote, Matthew C. Burmeister, Bryan Burmeister, Elizabeth et al.

Source: ANZ Journal of Surgery. Apr2008, Vol. 78 Issue 4, p273-276. 4p. 1 Chart, 3 Graphs.

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

Authors: Gebski, Val Burmeister, Bryan Smithers, B Mark et al.

Source: Lancet Oncology. Mar2007, Vol. 8 Issue 3, p226-234. 9p.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Authors: Burmeister, Bryan H Smithers, B Mark Gebski, Val et al.

Source: Lancet Oncology. Sep2005, Vol. 6 Issue 9, p659-668. 10p.

Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin.

Authors: Burmeister, Bryan H. Walpole, Euan T. Burmeister, Elizabeth A. et al.

Source: International Journal of Clinical Oncology. Aug2005, Vol. 10 Issue 4, p256-261. 6p.

Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum.

Authors: Burmeister, Bryan H. Schache, David Burmeister, Elizabeth A. et al.

Source: International Journal of Colorectal Disease. Jan2004, Vol. 19 Issue 1, p55-59. 5p. 4 Charts, 2 Graphs.

Preservation of Form and Function in the Management of Head and Neck Skin Cancer World J. Surg. Vol. 27, No. 7, July 2003.

Authors: Poulsen, Michael Burmeister, Bryan Kennedy, Dan

Source: World Journal of Surgery. Jul2003, Vol. 27 Issue 7, p868-874. 7p.

Merkel Cell Carcinoma in Queensland: Treatment, Incidence and Outcomes Over a 10‐Year Period (2012–2021)

Authors: Youlden, Danny R. Gujadhur, Shabnam Nath, Artika et al.

Source: Australasian Journal of Dermatology. May2026, p1. 8p. 3 Illustrations.

Evaluation of the clinical outcomes and patient satisfaction related to the use of internal eye shields for electron external beam radiation therapy.

Authors: Tait, Kirsty Burgess, Sinead Burmeister, Elizabeth A. et al.

Source: Journal of Medical Radiation Sciences. Dec2024, Vol. 71 Issue 4, p555-563. 9p.

Radiation Therapy Fields of Dreams: We Built Them—But Did They Come?

Authors: Adams, Gerard Guan, Tracey Lee Burmeister, Elizabeth Anne et al.

Source: Journal of Medical Imaging & Radiation Oncology. Apr2026, p1. 6p.